Caregen Co., Ltd.

Equities

A214370

KR7214370009

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
21,400 KRW +0.71% Intraday chart for Caregen Co., Ltd. +5.68% -22.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Caregen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Caregen's Net Income Jumps 88.2% in Q1 MT
Nomura Starts Caregen at Buy With KRW270,000 Price Target MT
Caregen Co., Ltd.(KOSDAQ:A214370) added to S&P Global BMI Index CI
Caregen Co., Ltd.'s Equity Buyback announced on April 24, 2020, has expired. CI
Caregen Co., Ltd. announces an Equity Buyback for 150,000 shares. CI
Caregen Co., Ltd. authorizes a Buyback Plan. CI
Caregen Co., Ltd.(KOSDAQ:A214370) dropped from S&P Global BMI Index CI
Tranche Update on Caregen Co., Ltd.'s Equity Buyback Plan announced on January 7, 2019. CI
Caregen Co., Ltd.'s Equity Buyback announced on January 7, 2019, has expired with 199,343 shares, representing 1.96% for KRW 14,308.71 million. CI
Caregen Co., Ltd. announces an Equity Buyback for 200,000 shares. CI
Caregen Co., Ltd. authorizes a Buyback Plan. CI
Tranche Update on Caregen Co., Ltd.'s Equity Buyback Plan announced on November 6, 2018. CI
Caregen Co., Ltd.'s Equity Buyback announced on November 6, 2018, has closed with 80,000 shares, representing 0.78% for KRW 6,185.55 million. CI
Caregen Co., Ltd. announces an Equity Buyback for 80,000 shares, for KRW 6,320 million. CI
Caregen Co., Ltd. authorizes a Buyback Plan. CI
An unknown buyer acquired 7.4% stake in Caregen Co., Ltd. from Shanghai Siyanli Industrial Co., Ltd. for KRW 56.2 billion. CI
An unknown buyer cancelled the acquisition of an unknown minority stake in Caregen Co., Ltd. from Winnova Co.,Ltd. CI
Tranche Update on Caregen Co., Ltd.'s Equity Buyback Plan announced on December 7, 2016. CI
Caregen Co., Ltd.'s Equity Buyback announced on December 7, 2016, has closed with 250,000 shares, representing 2.75% for KRW 19,444.62 million. CI
Caregen Co., Ltd. announces an Equity Buyback for 250,000 shares. CI
Caregen Co., Ltd. authorizes a Buyback Plan. CI
Tranche Update on Caregen Co., Ltd.'s Equity Buyback Plan announced on October 13, 2016. CI
Caregen Co., Ltd.'s Equity Buyback announced on October 13, 2016 has closed with 257,730 shares, representing 2.4% for KRW 20,193.76 million. CI
Caregen Co., Ltd. announces an Equity Buyback for 257,730 shares, for KRW 24,999.81 million. CI
Chart Caregen Co., Ltd.
More charts
Caregen Co., LTD is a Korea-based company mainly engaged in the manufacture of cosmeceuticals and dermal fillers. The Company manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The Company distributes its products within domestic market and to overseas markets.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A214370 Stock
  4. News Caregen Co., Ltd.
  5. Caregen's Net Income Jumps 88.2% in Q1